These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9825331)
1. The effect of DDD pacing on ergospirometric parameters and neurohormonal activity in patients with hypertrophic obstructive cardiomyopathy. Simantirakis EN; Kanoupakis EM; Kochiadakis GE; Kanakaraki MK; Parthenakis FI; Manios EG; Markianos E; Vardas PE Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2269-72. PubMed ID: 9825331 [TBL] [Abstract][Full Text] [Related]
2. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815 [TBL] [Abstract][Full Text] [Related]
3. Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy. Lucon A; Palud L; Pavin D; Donal E; Behar N; Leclercq C; Mabo P; Daubert JC Arch Cardiovasc Dis; 2013; 106(6-7):373-81. PubMed ID: 23806305 [TBL] [Abstract][Full Text] [Related]
4. Long-term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy >50 years of age. Topilski I; Sherez J; Keren G; Copperman I Am J Cardiol; 2006 Jun; 97(12):1769-75. PubMed ID: 16765132 [TBL] [Abstract][Full Text] [Related]
5. The importance of ventricular septal morphology in the effectiveness of dual chamber pacing in hypertrophic obstructive cardiomyopathy. Dimitrow PP; Grodecki J; Bacior B; Dudek D; Legutko J; Jaszcz KK; Dubiel JS Pacing Clin Electrophysiol; 2000 Sep; 23(9):1324-9. PubMed ID: 11025886 [TBL] [Abstract][Full Text] [Related]
6. c-AMP and ANP levels in VVI and DDD pacing with different AV delays during daily activity and exercise. Theodorakis G; Kremastinos D; Livanis MM; Archontakis C; Karavolias G; Toutouzas P Pacing Clin Electrophysiol; 1990 Dec; 13(12 Pt 2):1773-8. PubMed ID: 1704539 [TBL] [Abstract][Full Text] [Related]
7. Results of permanent dual-chamber pacing in symptomatic nonobstructive hypertrophic cardiomyopathy. Cannon RO; Tripodi D; Dilsizian V; Panza JA; Fananapazir L Am J Cardiol; 1994 Mar; 73(8):571-6. PubMed ID: 8147303 [TBL] [Abstract][Full Text] [Related]
8. Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest. Gadler F; Linde C; Juhlin-Dannfelt A; Ribeiro A; Rydén L Eur Heart J; 1997 Apr; 18(4):636-42. PubMed ID: 9129895 [TBL] [Abstract][Full Text] [Related]
9. Impact of right atrial-left ventricular dual-chamber permanent pacing in patients with severely symptomatic hypertrophic obstructive cardiomyopathy. Honda T; Shono H; Koyama J; Tsuchiya T; Hayashi M; Hirayama T; Uesugi H; Honda T Circ J; 2005 May; 69(5):536-42. PubMed ID: 15849439 [TBL] [Abstract][Full Text] [Related]
11. Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points. Ommen SR; Nishimura RA; Squires RW; Schaff HV; Danielson GK; Tajik AJ J Am Coll Cardiol; 1999 Jul; 34(1):191-6. PubMed ID: 10400010 [TBL] [Abstract][Full Text] [Related]
12. Impact of chronic DDD pacing on time-domain indexes of heart rate variability in patients with hypertrophic obstructive cardiomyopathy. Simantirakis EN; Kochiadakis GE; Kanakaraki MK; Marketou ME; Parthenakis FI; Kanoupakis EM; Vardas PE Pacing Clin Electrophysiol; 1999 Dec; 22(12):1808-13. PubMed ID: 10642136 [TBL] [Abstract][Full Text] [Related]
13. Total sympathetic activity and atrial natriuretic factor levels in VVI and DDD pacing with different atrioventricular delays during daily activity and exercise. Theodorakis GN; Kremastinos DT; Markianos M; Livanis E; Karavolias G; Toutouzas PK Eur Heart J; 1992 Nov; 13(11):1477-81. PubMed ID: 1334465 [TBL] [Abstract][Full Text] [Related]
14. Effects of dual-chamber pacing for pediatric patients with hypertrophic obstructive cardiomyopathy. Rishi F; Hulse JE; Auld DO; McRae G; Kaltman J; Kanter K; Williams W; Campbell RM J Am Coll Cardiol; 1997 Mar; 29(4):734-40. PubMed ID: 9091517 [TBL] [Abstract][Full Text] [Related]
15. Rationale and design of the TRICHAMPION trial: Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy Patients. Berruezo A; Linhart M; Auricchio A; Zamorano JL; Santamaria P; Borràs R; Burgos F; Brugada J J Interv Card Electrophysiol; 2018 Mar; 51(2):117-124. PubMed ID: 29397524 [TBL] [Abstract][Full Text] [Related]
16. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. Nishimura RA; Trusty JM; Hayes DL; Ilstrup DM; Larson DR; Hayes SN; Allison TG; Tajik AJ J Am Coll Cardiol; 1997 Feb; 29(2):435-41. PubMed ID: 9015001 [TBL] [Abstract][Full Text] [Related]
17. [Long-term beneficial effect of dual chamber pacing in a patient with hypertrophic obstructive cardiomyopathy]. Takahashi M; Horinaka S; Takada M; Matsumoto N; Tsuchiya N; Yabe A; Onoda M; Murate J; Masuda T; Ishikawa K; Takeda K; Matsuoka H J Cardiol; 1997 Jun; 29(6):345-52. PubMed ID: 9211094 [TBL] [Abstract][Full Text] [Related]
18. [Pacemaker therapy of hypertrophic obstructive cardiomyopathy. PIC (Pacing in Cardiomyopathy) Study Group]. Meisel E; Rauwolf T; Burghardt M; Kappenberger L Herz; 2000 Jun; 25(4):461-6. PubMed ID: 10948782 [TBL] [Abstract][Full Text] [Related]